What Percentage of Pediatric Myopia Patients Use Myopia Control Treatments Like Atropine, Ortho-K, or Special Lenses?

What are the Current Uptake Rates for Low-Dose Atropine?

Low-dose atropine is currently the most widely used myopia control treatment due to its ease of use and low cost. Approximately 15 percent of pediatric myopes are prescribed atropine drops, which are typically used once nightly. These drops work by signaling the eye to slow its axial growth without significantly affecting the child's ability to focus or their pupil size. Because it does not require specialized hardware like contact lenses, it is often the first-line treatment recommended for very young children or those who are not yet ready for contact lens wear.

How Often are Orthokeratology (Ortho-K) Lenses Prescribed?

Orthokeratology, or Ortho-K, is used by approximately 8 percent to 12 percent of children in active myopia management programs. These specialized rigid lenses are worn only during sleep to temporarily reshape the cornea, allowing the child to see clearly during the day without any correction. The primary benefit of Ortho-K is the "peripheral defocus" it creates on the retina, which is a powerful signal to the brain to stop eyeball elongation. While highly effective, Ortho-K requires more frequent follow-up visits and a higher level of hygiene than other treatment modalities.

What is the Role of Specialized Myopia Control Spectacle Lenses?

Specialized spectacle lenses are the newest addition to the myopia control toolkit and are gaining rapid adoption in international markets. These lenses, such as DIMS or HALT technology, are being used by about 5 percent to 10 percent of pediatric patients. Unlike standard glasses, these lenses have hundreds of tiny "segments" that create peripheral defocus while maintaining a clear center for distance vision. They are an excellent option for children who are afraid of eye drops or are too young to handle contact lenses safely.

How Do Practice Patterns Differ Across Different Age Groups?

Treatment choices are heavily influenced by the child's age and maturity level. For children under the age of seven, low-dose atropine is the dominant choice because it is non-invasive and requires minimal cooperation. As children reach the ages of nine to twelve, many transition to Ortho-K or multifocal soft contact lenses as they begin to participate in sports and become more responsible for their own hygiene. Clinicians often use a "combination therapy" approach for older children who are still progressing rapidly despite being on a single treatment.

Why is Early Intervention the Key to Successful Myopia Management?

The goal of myopia control is to keep the final prescription under negative five diopters to avoid the risk of permanent blindness later in life. Every year that treatment is delayed allows the eye to continue its path of unhealthy elongation. Data shows that starting treatment as soon as myopia is detected?even if the prescription is low?provides the best long-term protection for the retina. Waiting until a child's vision is "bad enough" is no longer the clinical standard, as the focus has shifted entirely toward lifetime risk reduction.